Clinical Trial Update: Development of Immune Globulin Treatment for Avian Flu [Phase 2]

View source ↗

Summary

A Phase 2 trial of intravenous immunoglobulin for avian influenza was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Infectious Diseases, Influenza | Phase 2 | Status: TERMINATED | Results posted: 2013-05-27